FIELD: medicine, laboratory methods of research.
SUBSTANCE: define biochemical indicators of blood at sick of a chronic virus hepatitis C: triglycerides, lipoproteins of low density, a thymol turbidity test, apolipoprotein B. On the obtained indicators calculate value of discriminant function using the formula: DF=1.298·x1+3.717·x2+0.954·x3+6.776·x4, where x1 - triglycerides, mmol/l; x2 - lipoproteins of low density, mmol/l; x3 - a thymol turbidity test, units; x4 - apolipoprotein B, g/l. On the obtained value with the help nomographic chart establish probability of presence of a cholesterosis of a gall bladder.
EFFECT: increase of accuracy of revealing of cholesterosis of gall bladder at sick of chronic virus hepatitis C.
1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPMENT OF LIPID DISTRESS SYNDROME IN CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2710254C1 |
| METHOD FOR PREDICTION OF LIPID DISTRESS SYNDROME DEVELOPMENT IN PATIENTS WITH STABLE VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C | 2019 |
|
RU2710264C1 |
| METHOD FOR PREDICTION OF A STABLE VIROLOGIC RESPONSE TO THERAPY OF CHRONIC HEPATITIS C WITH PREPARATIONS OF DIRECT ANTIVIRAL ACTION IN THE PRESENCE OF LIPID DISTRESS SYNDROME | 2019 |
|
RU2710257C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC FIBROSIS ACCOMPANYING VIRAL HEPATITIS C | 2014 |
|
RU2557927C1 |
| METHOD OF FATTY LIVER DISEASE DIAGNOSTICS IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS C | 2006 |
|
RU2347226C2 |
| METHOD FOR PREDICTION OF DEVELOPING METABOLIC SYNDROME IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2018 |
|
RU2684524C1 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC VIRAL HEPATITIS C IN CHILDREN | 2024 |
|
RU2833499C1 |
| DIAGNOSTIC TECHNIQUE FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2024 |
|
RU2827361C1 |
| METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
